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Sox4 expression is restricted in mammals to embry-
onic structures and some adult tissues, such as
lymphoidorgans,pancreas, intestine,andskin.During
embryogenesis, Sox4 regulates mesenchymal and
neural progenitor survival, as well as lymphocyte and
myeloid differentiation, and contributes to pancreas,
bone, and heart development. Aberrant Sox4 expres-
sion is linked to malignant transformation and metas-
tasis in several types of cancer. To understand the
role of Sox4 in the adult organism, we first generated
mice with reduced whole-body Sox4 expression.
These mice display accelerated aging and reduced
cancer incidence. To specifically address a role for
Sox4 in adult stem cells, we conditionally deleted
Sox4 (Sox4cKO) in stratified epithelia. Sox4cKO mice
show increased skin stem cell quiescence and resis-
tance to chemical carcinogenesis concomitantly with
downregulation of cell cycle, DNA repair, and acti-
vated hair follicle stem cell pathways. Altogether,
these findings highlight the importance of Sox4 in
regulating adult tissue homeostasis and cancer.
INTRODUCTION
Adult organs are maintained through a balance of proliferation,
differentiation, and self-renewal of stem cells that take place
during normal tissue homeostasis or to repair tissue damage
(Sharpless and DePinho, 2007). Alterations in this equilibrium
can result in decreased organ function and are linked to degen-
erative processes such as cancer and aging (Garinis et al., 2008;
Hoeijmakers, 2009; Lo´pez-Otı´n et al., 2013).
The skin is the largest of all themammalian organs and its prin-
cipal function is to provide protection from external aggressions
and dehydration (Fuchs, 2007). It is composed of a supportiveconnective tissue (dermis) and a stratified epithelium (epidermis).
The epithelium comprises the interfollicular epidermis (IFE) and
its appendages, namely, the sebaceous glands (SGs) and the
hair follicles (HFs) (Blanpain and Fuchs, 2009; Watt, 2001). The
epidermis is very dynamic and is maintained through bouts of
activation of its stem cells, located in the HFs (HF stem cells
[HFSCs]) in the bulge and hair germ (HG) regions, which are iden-
tified by expression of CD34, cytokeratin 15, and Lgr5 markers
(Greco et al., 2009; Hsu et al., 2011; Solanas and Benitah,
2013). HFSC activation occurs throughout the entire life of the or-
ganismduring the hair cycle, which alternates among resting (tel-
ogen), proliferation and differentiation (anagen), and destructive
(catagen) phases (Alonso and Fuchs, 2006; Mu¨ller-Ro¨ver et al.,
2001). The alternation among these states is orchestrated by
the dermal papilla, which provides the signals required for
HFSC activation to the lower-bulge and HG stem cells through
the TGFb, Notch, and Wnt/Ctnnb1 pathways (Greco et al.,
2009; Lien et al., 2014; Oshimori and Fuchs, 2012; Rendl et al.,
2008; Solanas and Benitah, 2013). Upper-bulge stem cells
(whose markers include Gli1, Lrig1, and Lgr6, among others)
also rely on Shh signals to contribute to IFE replenishment during
wound repair, but not to HF cycling (Jensen et al., 2009; Solanas
and Benitah, 2013). The molecular signature of resting and acti-
vated HFSCs has been extensively studied by transcriptional
profiling. The results showed that whereas dormant HFSCs
are enriched in factors that promote quiescence and/or self-
renewal, including Lhx2, Lgr5, Lgr6, Lrig1, and CD34, among
others (Braun et al., 2003; Jaks et al., 2008; Jensen et al.,
2009, 2010; Nowak et al., 2008; Rhee et al., 2006; Snippert
et al., 2010), activation of HFSCs occurs in a stepwise manner
with increased expression of genes controlled by the canonical
Wnt/Ctnnb1 pathway, most of which are involved in cell-cycle
progression, differentiation, extracellular matrix/adhesion, and
transcription (Greco et al., 2009; Lien et al., 2014). Among
them, Sox4 (Sry-related High Mobility Group [HMG] box-con-
taining transcription factor 4) was found to be upregulated 5-
fold by microarray-based transcriptional profiling (Greco et al.,
2009; Kobielak et al., 2007; Lien et al., 2014; Lowry et al., 2005).Cell Reports 8, 487–500, July 24, 2014 ª2014 The Authors 487
Sox4 belongs to the SoxC class of transcription factors, en-
compassing Sox4, Sox11, and Sox12 (Harley and Lefebvre,
2010). Sox4 is expressed mainly during embryonic development
in the neural crest, mesenchyme, developing pancreas, thymus,
spleen, and HFs (Dy et al., 2008; Hoser et al., 2008; Lioubinski
et al., 2003). In adults, Sox4 expression is found in a limited set
of tissues, including the female reproductive system, hematopoi-
etic system, pancreatic islets, intestinal crypts, and activated
HFSCs and HG cells (Deneault et al., 2009; Greco et al., 2009;
Hunt andClarke, 1999; Lien et al., 2014; Lowry et al., 2005; Schil-
ham et al., 1997; Van der Flier et al., 2007; Wilson et al., 2005).
The main functions attributed to Sox4 are the regulation of sur-
vival and proliferation of neural and mesenchymal progenitors
(Bhattaram et al., 2010), cardiac outflow formation (Schilham
et al., 1996), pancreatic islet and osteoblast development (Nis-
sen-Meyer et al., 2007; Wilson et al., 2005), B and T cell matura-
tion (Kuwahara et al., 2012; Schilham et al., 1997), and myeloid
differentiation (Aue et al., 2011; Sandoval et al., 2012). The con-
strictions in expression of Sox4 by adult cells suggest that a tight
regulation is required to maintain an adequate tissue homeosta-
sis. Indeed, aberrant Sox4 expression in adult tissues is linked to
cancer onset and progression in mice and humans (Jafarnejad
et al., 2013; Vervoort et al., 2013).
The first proof that Sox4 could act as an oncogene was the
finding that theSox4 locus is one of the common integration sites
in genome-wide tagging protocols based on retroviral-mediated
activation of proto-oncogenes (Du et al., 2005; Li et al., 2007;
Shin et al., 2004). Since then, Sox4 overexpression has been
found in virtually all major cancer types, including lung, bladder,
prostate, hepatic, gastric, neural, and hematopoietic cancers
(Vervoort et al., 2013). Overexpression of Sox4 is sufficient to
induce transformation in the hematopoietic compartment by
blocking myeloid differentiation (Aue et al., 2011; Boyd et al.,
2006; Omidvar et al., 2013; Sandoval et al., 2012; Zhang et al.,
2013). Furthermore, Sox4 inhibits apoptosis and increases cell
proliferation (Hur et al., 2010). Interestingly, abrogation of Sox4
in medulloblastoma cell lines increases their sensitivity to
ionizing radiation (IR), indicating that this protein confers DNA
damage resistance to this type of cancer cells (Chetty et al.,
2012). Finally, Sox4 is crucial in different steps of metastatic
colonization, being regulated through the Wnt pathway, trans-
forming growth factor b (TGF-b) cues and endogenous miRNAs
to promote epithelial-to-mesenchymal transition (EMT) through
Ezh2-mediated epigenetic reprogramming and regulation of
cancer cell proliferation (Parvani and Schiemann, 2013; Tavazoie
et al., 2008; Tiwari et al., 2013; Vervoort et al., 2013).
Several mouse models for studying Sox4 have been gener-
ated. Sox4-null (Sox4/) mice die in utero at embryonic day
14.5 (E14.5) bearing cardiac malformations, incomplete pancre-
atic islet development, and defects in lymphoid maturation
(Schilham et al., 1996). Sox4+/ mice show decreased bone
mineralization due to impaired osteoblast development (Nis-
sen-Meyer et al., 2007). Sox4 deletion in hematopoietic cells
results in impaired B and T cell maturation and its overexpres-
sion blocks myeloid differentiation (Kuwahara et al., 2012; Sun
et al., 2013; Zhang et al., 2013). A recent report also showed
that Sox4 deletion in renal progenitors results in premature kid-
ney dysfunction (Huang et al., 2013).488 Cell Reports 8, 487–500, July 24, 2014 ª2014 The AuthorsSox4 is the only SoxC class member that is expressed in skin.
In particular, Sox4 has been detected in the upper and lower
bulge in HFs during morphogenesis at E18.5 (Dy et al., 2008),
during the telogen-to-anagen transition in activated HFSCs
from the bulge and HG (Greco et al., 2009; Lien et al., 2014;
Lowry et al., 2005), and in E6/E7 oncogene-mediated or
Bmpr1cKO-driven activated HFSCs (da Silva-Diz et al., 2013;
Kobielak et al., 2007). Specifically, Sox4 responds to canonical
Wnt signals in activated HFSCs in a Ctnnb1-sensitive manner
during hair regeneration after plucking (Lien et al., 2014). Never-
theless, the functions of Sox4 in most adult tissues, and particu-
larly in skin homeostasis and cancer, remain largely unknown.
Here, we sought to address the roles of Sox4 in adult tissue
homeostasis and cancer. We generated a mouse model with
downregulated expression of Sox4 in most tissues (Sox4lox/lox
mice). These mice are viable and fertile, but are smaller in size
than their wild-type (WT) littermates. Hypomorphic Sox4lox/lox
mice develop a panel of premature age-associated pathologies
and a significantly reduced longevity. In addition, these mice are
cancer resistant. Specific deletion of Sox4 in skin (Sox4cKOmice)
results in normal skin stratification. However, Sox4 deficiency in
skin hampers normal HFSC activation upon forced proliferative
cues. When subjected to a chemically induced skin carcinogen-
esis protocol, Sox4cKO mice show a strong resistance to tumor
development. Finally, we explain these phenotypes by identi-
fying a Sox4-associated transcriptional regulation of gene sets
associated with cell division, DNA repair, and HFSC activation.
Altogether, our results shed light on some crucial functions of
this protein in cancer and aging and provide new tools for eluci-
dating Sox4 function in adult tissues.
RESULTS
Generation of Knockin Sox4 Mice
The fact that complete Sox4 abrogation (Sox4/mice) results in
embryonic lethality (Schilham et al., 1996) has hampered efforts
to understand the role of Sox4 in the adult organism. To circum-
vent this, we decided to generate a Sox4 knockin (KI) mouse
model (Sox4lox/lox mice) that would allow us to track Sox4-ex-
pressing cells in vivo and conditionally delete Sox4 in adult tis-
sues. To that end, we generated a KI construct targeted to the
Sox4 locus, including the whole Sox4 50 UTR and 30 UTR and
the full-length Sox4 unique exon adjacent to an IRES-FP-Lucif-
erase (GFP-Luc) reporter coding sequence. We flanked the KI
allele with LoxP sites in order to allow the excision of the whole
cassette with tissue-specific Cre recombinase. When intact,
the KI cassette is regulated by the endogenous Sox4 promoter,
and its transcription is expected to give rise to the full-length
Sox4 protein and the GFP-Luc reporter simultaneously (Figures
1A and 1B).
Sox4lox/lox Mice Show Signs of Premature Aging and Are
Cancer Resistant
The Sox4lox/lox mice were viable and fertile and did not show
signs of embryonic lethality at E13.5 or E18.5; however, they dis-
played sub-Mendelian ratios at weaning (Figure S1A), suggest-
ing a selection in the litters. We attributed this to the delayed
weight and size gain in the earliest postnatal stages (Figures
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Figure 1. Sox4lox/lox Mice Display Cancer Resistance and Accelerated Aging
(A) Schematic representation of the different Sox4 alleles. The genotyping primers (red arrows) and PCR sizes in base pairs (bp) are depicted.
(B) Genotyping PCR of the different Sox4 alleles.
(C) Macroscopic aspect of Sox4+/+ and Sox4lox/lox mice. Increased pigmentation in exposed skin is indicated by red arrowheads.
(D) Body weight of mice of the indicated genotypes.
(E) Left: Kaplan-Meyer survival curves; p values refer to comparison with Sox4+/+ mice (log rank test). Dashed red line indicates mean lifespan. Right: lifespan of
the ten longest-lived mice of the indicated genotype.
(F) Bone mineral density (BMD) of Sox4+/+ and Sox4lox/lox mice.
(legend continued on next page)
Cell Reports 8, 487–500, July 24, 2014 ª2014 The Authors 489
S1B and S1C). The reduced body size and weight of Sox4lox/lox
mice was maintained through their entire lifespan (Figures 1C
and 1D). Dual-energy X-ray absorptiometry (DEXA) indicated
that the reduced weight was due to a decrease in both lean
and fat mass (Figures S1D–S1F). In addition, Sox4lox/lox mice
had a significantly reduced longevity when compared with
Sox4+/+ or Sox4+/lox mice (Figures 1E and S1G). This decreased
survival paralleled the early onset of various age-associated pa-
thologies. In particular, Sox4lox/lox mice presented decreased
bone mineral density (Figure 1F) and a higher incidence of intes-
tinal failure, chronic hepatic failure, skin hyperpigmentation, and
dilated cardiomyopathy (Figures 1C and 1G; Table S1). We also
found a significantly increased incidence of congenital diaphrag-
matic hernia and pyometra (Figure 1G; Table S1). Furthermore,
the humane endpoint (HEP) was reached significantly earlier in
Sox4lox/lox compared with control mice (Figures 1E and S1G;
Table S1). This reduced longevity coincided with a notable
reduction in the mean telomere length of peripheral blood cells,
a bona fide indicator of biological aging (Canela et al., 2007; de
Jesus and Blasco, 2012; Lo´pez-Otı´n et al., 2013; Vera et al.,
2012; Figure 1H). Interestingly, these mice displayed a reduced
spontaneous cancer incidence when compared with Sox4+/+
mice (Figure 1I). Together, these findings indicate that Sox4lox/lox
mice show signs of premature loss of tissue homeostasis and
subsequently an accelerated onset of age-associated pathol-
ogies concomitantly with cancer resistance.
Sox4lox/lox Mice Are Hypomorphic
The above results showed that the Sox4 KI allele exhibits hypo-
morphic behavior. In order to confirm this, we performed indirect
immunohistochemistry (IHC) for GFP in tail skin sections, given
that Sox4 mRNA has been detected in skin (Dy et al., 2008;
Greco et al., 2009; Lowry et al., 2005). We failed to detect any
positive GFP signal (Figure S2A), indicating either very low
expression levels of the KI cassette or decreased Sox4 expres-
sion in adult mouse skin. To quantify Sox4 mRNA expression
levels in Sox4lox/lox mice, we performed Sox4 real-time quantita-
tive RT-PCR (qPCR) in a panel of tissues from both Sox4lox/lox
and Sox4+/+ mice. Sox4lox/lox mice showed an 10-fold reduc-
tion in Sox4mRNA levels in all analyzed tissues when compared
with WT littermates (Figure 1J). Of note, we did not detect a high
variability in Sox4 expression levels among the Sox4lox/lox mice
tested, indicating that the Sox4 hypomorphic allele is expressed
similarly in surviving adult mice (Figure S2B). Notably, we did not
detect any significant deregulation of the other SoxC classmem-
bers (Sox11 and Sox12) in the analyzed tissues (Figure S2C).
Altogether, these findings demonstrate that the Sox4lox/lox
mouse model described herein behaves as a functional hypo-
morph for Sox4 mRNA expression levels and thus constitutes(G) Representative images of Sox4lox/lox mice at the HEP. Green arrowhead ma
diomyopathy, and blue arrowhead points to pyometra.
(H) High-throughput QFISH in mice of the indicated age and genotype.
(I) Spontaneous cancer incidence in the indicated genotypes. Fisher’s exact test
(J) qPCR of Sox4 mRNA in the indicated tissues of Sox4+/+ and Sox4lox/lox mice.
The p values and number of mice per genotype (n) are indicated (two-tailed Stud
error bars are SEM.
See also Figures S1 and S2, and Tables S1 and S5.
490 Cell Reports 8, 487–500, July 24, 2014 ª2014 The Authorsa viable adult mouse model with whole-body reduced Sox4
expression.
Generation of a Sox4 Conditional KO Mouse Model in
Stratified Epithelia
The above results indicate that adult mice with reduced Sox4
levels show a faster loss of normal tissue homeostasis. As the
latter relies on a controlled balance between tissue replenish-
ment and degeneration, we hypothesized that organ failure
could be due to defects in the activity of adult stem cells. Up
to now, Sox4 has been the only SoxC class member shown to
be expressed in developing and adult skin, mostly in activated
HFSCs and HG during the telogen-to-anagen transition (Dy
et al., 2008; Greco et al., 2009; Lien et al., 2014; Lowry et al.,
2005). Moreover, Sox4lox/lox mice showed an increased inci-
dence of skin hyperpigmentation at the HEP (Figure 1C; Table
S1) and a delayed onset of the placode-to-HF transition during
hair morphogenesis (Figure S2D), with the latter suggesting
delayed activation of HFSCs (Nowak et al., 2008). In order to
test this, we abrogated Sox4 in skin to model adult stem cell
function. We crossed Sox4lox/lox mice with K5-Cre transgenic
mice (Ramirez et al., 2004), giving rise to Sox4+/+; K5-CreTg/+
(Sox4WT) and Sox4lox/lox; K5-CreTg/+ (Sox4cKO) mice. As ex-
pected, the Sox4cKO mice were viable and lacked Sox4 mRNA
expression in tail skin epidermis when compared with Sox4WT,
and showed no differences in Sox11 and Sox12 (Figures 2A,
2B, and S3A). Of note, we did not find any significant change
in the lifespan of Sox4+/+; K5CreTg/+ when compared with
Sox4+/+; K5Cre+/+ mice, Sox4+/lox; K5CreTg/+ (Sox4cHET) com-
pared with Sox4+/lox; K5Cre+/+ mice, or Sox4lox/lox; K5CreTg/+
versus Sox4lox/lox; K5Cre+/+ mice (Figure S3B). Therefore, unless
specifically mentioned otherwise, hereafter we refer to Sox4+/+;
K5CreTg/+ and Sox4+/+; K5Cre+/+ mice collectively as Sox4WT
mice.
Sox4 Is Dispensable for Normal Skin Stratification
In order to assess the role of Sox4 in skin, we studied several dif-
ferentiation markers in Sox4cKO and Sox4WT mice. We did not
find differences in the assembly or disposition of cytokeratin
10 (CK10, committed basal keratinocytes), CK14 (epidermal ker-
atinocytes), or loricrin (terminally differentiated, cornified layer of
keratinocytes) (Fuchs, 1994; Figure 2C). In addition, Sox4cKO
mice displayed a normal hair coat upon gross examination (Fig-
ure 2A), indicating that Sox4 is largely dispensable for normal
skin stratification. Finally, sinceSox4cKOmicewere hypomorphic
for Sox4 expression in the rest of the tissues, they also displayed
a reduced size, decreased weight, and shorter lifespan, thus
recapitulating the phenotypes observed in Sox4lox/lox mice (Fig-
ures S3B–S3D).rks congenital diaphragmatic hernia, yellow arrowhead indicates dilated car-
was used for comparison.
ent’s t test was used unless specified otherwise). Bars depict average values,
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Figure 2. Normal Skin Stratification in the Absence of Sox4 and Reduced Replicative History in Sox4cKO Bulge Cells
(A) Sox4WT and Sox4cKO mice at 6 months of age. Orange arrowheads mark hyperpigmentation.
(B) Sox4 qPCR in skin epidermis of the indicated genotypes.
(C) IHC for CK14, CK10, and loricrin in tail skin sections from adult Sox4WT and Sox4cKO mice. Insets depict magnification. The images are representative of five
mice per genotype.
(D) QFISH on the tail skin (bulge region) of an adult mouse (6 months old). The IFE and bulge are indicated in the images (middle panels: magnification [Magn.]).
(E) Mean telomere length (left panel), percentage of short telomeres (middle panel), and long telomeres (right panel) from the bulge region. n, number of analyzed
mice per genotype; error is SEM; p values are indicated (two-tailed Student’s t test). Scale bars are depicted in graphs.
See also Figure S3.Decreased Replicative History in Sox4-Depleted Bulge
Cells
Sox4 is expressed in the skin in adult stem cell compartments
such as the bulge and HG upon physiological or forced HFSC
activation, including hair morphogenesis, normal hair cycling,
plucking-induced anagen, Bmpr1cKO-mediated HFSC activa-
tion, and oncogenic E6/E7-driven bulge stem cell mobilization
(da Silva-Diz et al., 2013; Dy et al., 2008; Greco et al., 2009; Ko-
bielak et al., 2007; Lien et al., 2014; Lowry et al., 2005).Moreover,
Sox4 has been strongly linked to regulation of stem cell activity
by controlling crucial steps such as differentiation and induction
proliferation (Lefebvre et al., 2007). Therefore, we aimed to
address whether Sox4 could also modulate HFSC activity. We
reasoned that the effects of such regulation should become
evident in the long term, and thus we measured telomere length
as a molecular indicator of the replicative history of the cells (Lo´-
pez-Otı´n et al., 2013). For this purpose, we performed quantita-
tive fluorescence in situ hybridization (QFISH), which allows the
determination of telomere length at a single-cell resolution
(Flores et al., 2008), in tail skin sections from 6-month-old
mice. We observed longer telomeres in the hair bulge of Sox4cKOmice as compared with WT controls, as reflected by an
increased mean telomere length and accumulation of long telo-
meres (Figures 2D and 2E). These results are suggestive of a
decreased replicative history in Sox4-depleted HFSCs (Flores
et al., 2008).
Sox4 Is Upregulated during Plucking and Is Required for
Normal Hair Regeneration
It is possible to force unscheduled entry into the hair cycle by
physically removing a portion of the hair coat. Following pluck-
ing, resting HFSCs and HG cells exit quiescence, become
activated, and proliferate while differentiating into all the hair lin-
eages (Keyes et al., 2013; Lien et al., 2014; Mu¨ller-Ro¨ver et al.,
2001). This activation of HFSCs is accompanied by changes in
their gene-expression signature such as upregulation of canon-
ical Wnt/Ctnnb1 signaling-related genes, including Sox4 (Greco
et al., 2009; Lien et al., 2014; Lowry et al., 2005). To explore Sox4
expression dynamics during the plucking-induced telogen-to-
anagen transition, we depilated a group of Sox4WT mice and
determined the mRNA expression levels for several markers of
HFSC activity.We found upregulation ofGATA3, Tcf3/4,mTERT,Cell Reports 8, 487–500, July 24, 2014 ª2014 The Authors 491
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Figure 3. Sox4 Is Induced after Hair Pluck-
ing and Is Required for Normal Hair Regen-
eration
(A) qPCR analysis of the indicated genes (NT, non-
treated; mid and late anagen, D6 and D12,
respectively) in WT mice. Two to three mice per
condition were analyzed.
(B) Sox4, Sox11, and Sox12 qPCR during pluck-
ing-induced anagen. n = 2–3 mice per condition.
Depicted is fold over NT.
(C) Left: hair regeneration dynamics in Sox4WT and
Sox4cKOmice. The initial pluckingarea isdelineated
by white dashed lines. Right: quantification of hair
regeneration at D12 after plucking as the means of
the regenerated area (%) with respect to that of
the initial plucked area. The genotype and number
(n) of mice are shown; p values were obtained
by Student’s t test; mean and SEM are depicted.
See also Figure S4.Sox9, and c-Myc mRNA in a stepwise manner, confirming
sequential activation of HFSCs after plucking (Greco et al.,
2009; Figure 3A). Sox4 was similarly induced during hair regen-
eration (Figure 3B). None of the other SoxC class members
showed significant changes after plucking, indicating a func-
tional specificity of Sox4 in the context of HFSC activation (Fig-
ure 3B). These results confirm that Sox4 is among the genes that
are induced during activation of HFSCs. To test whether Sox4 is
required for hair regeneration, we plucked Sox4WT and Sox4cKO
mice. We observed complete fur regeneration in Sox4WT mice
12–15 days after plucking, whereas Sox4cKO mice displayed a
delayed hair growth (Figure 3C).
The delay in hair regeneration together with the reduced repli-
cative history of HFSC in Sox4cKO mouse skin suggests that
Sox4 may be an important modulator of HFSC activation and
thus could serve relevant functions during skin regeneration.
Delayed HFSC Activation in the Absence of Sox4
We wanted to test the ability of HFSCs to regenerate the skin in
the absence of Sox4 (Keyes et al., 2013; Mu¨ller-Ro¨ver et al.,
2001). To this end, we performed skin histology and IHC analysis
12 days after plucking. First, we noted a significant reduction
in HF length, epidermal thickness, and dermis size in Sox4cKO
compared with Sox4WT, suggestive of diminished hair cycle in-
duction in the absence of Sox4 (Figures 4A and 4B; Flores
et al., 2005; Keyes et al., 2013; Mu¨ller-Ro¨ver et al., 2001). Simul-
taneously, there was an overall decrease in the number of prolif-
erating cells as evidencedbyKi67 staining in several skin regions,492 Cell Reports 8, 487–500, July 24, 2014 ª2014 The Authorsincluding the hair bulb and the hair prog-
eny compartments, further supporting
limited induction of hair cycling (Figures
4C and 4D). This was accompanied by
an increase in the percentage of gH2AX-
positive cells (Figures 4E and 4F) and
p53-positive cells, especially in activated
HFSC compartments such as the junc-
tional zone (JZ) and the bulge (Figures
4G and 4H). To confirm that Sox4 was
required for HFSC differentiation, we ex-tracted total keratinocytes from newborn and adult mice and
cultured them under clonogenic conditions in which only stem
cells can proliferate and differentiate, generating large colonies
arising from single cells (Blanco et al., 2011; Jensen et al.,
2010). After 2 weeks in culture, we observed a significant
reduction in the number of large, differentiated colonies in kerati-
nocytes bearing reduced expression of Sox4 in a dose- and age-
dependent manner (Figures 4I and S4A).
In mice, hair regeneration relies on the activity of HFSCs
located in the hair bulge and HG (Fuchs, 2009; Greco et al.,
2009). Other HFSC populations can also contribute to tissue
replenishment in regions other than the hair. Among them, JZ/
Lrig1-positive cells can provide input to the IFE under wounding
stimuli (Jensen et al., 2009). In order to specifically test whether
Sox4 also could be required for proper IFE regeneration upon
wounding, we performed wound-healing assays. In accordance
with delayed hair regeneration, Sox4cKO mice also displayed a
significant slowdown in replenishing the epidermis after wound-
ing (Figure 4J). This supports a general delayed response of
Sox4-deficient skin to proliferative stimuli in several HFSC/multi-
potent skin compartments and thus accounts for the reduced
regenerative capacity of several skin compartments.
Finally, we confirmed that both Sox4WT and Sox4cKO mice had
similar numbers of HFSCs, as indicated by a similar total number
of colonies (including small, undifferentiated ones) in the clono-
genic assays and by equal numbers of label-retaining cells
(Braun et al., 2003; Figures S4A and S4B). Together with the de-
layed hair morphogenesis, these results indicate that Sox4 plays
A B
C D
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G H
I J
Figure 4. Sox4 Is Required for Normal HFSC
Activation during Hair Regeneration and
Wound Healing
(A) Hematoxylin and eosin staining in Sox4WT and
Sox4cKO mouse back skin sections at D12 after
plucking. Skin regions are delineated by dashed
lines.
(B) HF length, epidermis thickness, and dermal
size from the experiment described in (A).
(C–H) Left: Ki67 (C), gH2AX (E), and p53 (G) IHCs
on back skin sections from Sox4WT and Sox4cKO
mice at D12 after plucking. Insets show magnifi-
cation. Prog, hair progeny; IFE, interfollicular
epidermis; JZ, junctional zone; HF, hair follicle;
Bulb, hair bulb. Representative pictures of five
mice per genotype. Right: Ki67- (D), gH2AX- (F),
and p53- (H) positive cells (% in the indicated
compartments) 12 days after plucking.
(I) Left: rhodamine staining of newborn primary
keratinocytes undergoing differentiation. Images
are representative of five to six mice per genotype.
Right: large, differentiated colonies (>3 mm) in
differentiating newborn (P1) and adult (P180) mice.
(J) Left: wound healing in Sox4WT and Sox4cKO
mouse skin at D0 and D8. Dashed circles mark the
initial wound area. Right: quantification of the re-
maining wound area (% of initial) at the indicated
days. n = 5 mice per genotype unless indicated
otherwise. Student’s t test was used. Depicted are
the average and SEM. Scale bars are included
within the micrographs.
See also Figure S4.a central role in modulating HFSC differentiation, but not during
HFSC specification and/or self-renewal.
Sox4 Is Required for the Coordinated Initiation of HFSC
Proliferation and Differentiation Programs
To dissect the molecular pathways underlying delayed HFSC
activation in Sox4-deficient skin, we performed microarray-
based gene-expression profiling in telogen (resting) and anagen
skin (Figures 5A, 5B, and S5A). Most of the differentially
expressed genes (DEGs; false discovery rate [FDR] < 0.15) in
telogen skin were related to immune response and choles-
terol/hormone metabolism, as revealed by gene set enrichment
analysis (GSEA; FDR < 0.05) and qPCR validation of some of
these genes, such as Defb8 or Aoah (Figures S5A–S5C; Table
S2). Given that Sox4 functions mainly as a transcriptional acti-
vator (van de Wetering et al., 1993) and its expression peaks
during late onset of anagen, we then focused on the genes
that were negatively regulated in Sox4cKO mice during pluck-
ing-induced anagen. A stringent analysis (FDR < 0.15) revealedCell Reports 8, 487–20 DEGs between Sox4WT and Sox4cKO
mouse skin undergoing hair regeneration
(Figure 5B; Table S3). Among them,
Sox4 was the most downregulated
gene (log2FC = 4.9; 30-fold decrease)
(Figure 5B; Table S3). We validated this
by qPCR on some of the DEGs,
including Tead2, Mex3a, Tes, Evl, andZfp184, all of which are known Sox4 targets (Bhattaram
et al., 2010; Figure 5C). Most of these DEGs are involved in ner-
vous system development, heart function, cytoskeleton remod-
eling, and cancer, as determined by Gene Ontology (GO)
studies (Table S3). All these processes have been previously
linked to Sox4 (Vervoort et al., 2013) and therefore provided
an additional biologically relevant quality control for our
microarray.
Next, we performed GSEA during plucking to gain insights
into the biological significance of these DEGs. GSEA revealed
a significant alteration (FDR < 0.05) of 86 signaling pathways
(extracted from the KEGG, Reactome, and NCI repositories)
in Sox4WT versus Sox4cKO mice (Table S4). We confirmed a
Sox4 signature in the anagen microarray by analyzing genes
identified by Liao et al. (2008) as an additional quality control
(Figures 5D and S5D; FDR = 2.6 3 1003). In addition, we
also observed very little overlap among the pathways that
were significantly downregulated in the absence of Sox4 in tel-
ogen versus anagen (Figure 5E), thus reinforcing the specific500, July 24, 2014 ª2014 The Authors 493
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role of Sox4 during the telogen-to-anagen transition, when the
HFSC become activated (Lien et al., 2014). The gene sets that
were downregulated in anagen Sox4cKO skin were mostly
related to cell cycle, HFSC activation, and DNA repair (Figures
5F and 5G; Table S4). These included critical mitotic regulators
such as CDK4, Bub1, and Ccne1, and genes of the DNA repli-
cation origin assembly such as Rcf3, Mcm7, and Mcm10 (Fig-
ures 5F and 5G). We also found downregulation of DNA repair
and replicative stress pathways in Sox4cKO mice undergoing
hair regeneration, in agreement with a role for Sox4 in the
DNA-damage response (Chetty et al., 2012; Figures 5F and
5G). Interestingly, several of the gene sets that were signifi-
cantly downregulated in the absence of Sox4 have been shown
to be crucial for proper HF cycling and activation/differentiation
of HFSCs (Berta et al., 2010; Lien et al., 2014; Nowak et al.,
2008; Oro and Higgins, 2003). In particular, we found downre-
gulation in the Myc and Shh pathways, in support of the previ-
ously shown delayed HFSC activation and wound repair (Fig-
ures 3C, 4I, 4J, 5F, and 5G). We further confirmed a
defective HFSC function by testing a Sox9 signature from the
Transfac repository. We observed a highly significant (FDR =
5.8 3 1003) downregulation of the Sox9 signature in Sox4cKO
mice undergoing anagen compared with Sox4WT controls (Fig-
ures 5D and S5D). We used the Sox5 signature as a negative
control because it did not show significant variation in our
microarray (Figures 5D and S6A). Finally, we compared our mi-
croarray data with the plucking-induced, Wnt-upregulated,
Ctnnb1-sensitive gene signature obtained by Lien et al.
(2014), a bona fide set of genes that govern HFSC activation
during plucking. Interestingly, we found a significant downregu-
lation of this set of genes (FDR < 1 3 1003) in Sox4-depleted
skin 12 days after plucking compared with their WT controls
(Figures 5F and 5G). We further validated most of these targets,
such as Gli1, Tcf7, Plk1, and Chk2, by qPCR (Figure 5H).
Importantly, most of these genes were not differentially regu-
lated in telogen Sox4cKO skin (Figures S5E and S5F). This
gene regulation exerted by Wnt/Ctnnb1 and modulated by
Sox4, which is exclusively restricted to activated skin, points
to a cooperation between Ctnnb1 and Sox4 in controlling target
genes that are relevant for HFSC activation during normal hair
regeneration.
Altogether, these results demonstrate that the absence of
Sox4 in skin results in delayed HFSC activation and subsequent
deficient induction of proliferation and differentiation pathways
concomitantly with defects in DNA damage repair, indicatingFigure 5. Sox4 Is Required for the Induction of Proliferative and Differe
(A) Ki67 dynamics during plucking, as assessed by IHC.
(B) Heatmap displaying the top 50 DEGs, as estimated by microarray gene profi
relative expression (log2FC) is scaled in color code (indicated).
(C) qPCR validation of some DEGs found in (B). Depicted is fold over Sox4WT for
(D) Enrichment plots from the Sox4, Sox9, and Sox5 signatures as assessed by
(E) Venn’s diagram comparing differentially downregulated pathways during telo
(F) Heatmaps of the top 20 genes from cell cycle (left), DNA repair (middle), and ca
Relative expression levels are color coded as indicated.
(G) Enrichment plots for the indicated pathways and processes.
(H) qPCR validation of Wnt/Ctnnb1 genes found downregulated in Sox4cKO anag
The FDR is included for the enrichment plots and number of genes per gene set (n
Number of mice (n) per genotype is indicated; average and SEM are plotted. Sethat Sox4 is a crucial modulator of pathways that control the
exit of HFSC quiescence.
Sox4 Deficiency Prevents Chemically Induced Skin
Carcinogenesis
We have shown cancer resistance in hypomorphic Sox4lox/lox
mice. Moreover, Sox4-deficient skin is resistant to HFSC activa-
tion, and several of the Sox4-regulated genes in our anagen mi-
croarray are related to cell-cycle regulation. In addition, Sox4 is
one of the most commonly upregulated genes in most cancer
types and is required for induction of proliferative and cell-
survival pathways (Vervoort et al., 2013). As the next step in
our study, we performed in vitro transformation protocols in
order to assess Sox4 dependency during cellular transformation
in mouse embryonic fibroblasts (MEFs). First, we assayed
Sox4lox/lox and Sox4+/+ MEFs previously transduced with
Adeno-Cre viruses to induce recombination of the KI allele
(hereafter termed Sox4lox/lox; AdCre and Sox4+/+; AdCre MEFs,
respectively). We transduced the cells with HRasG12V and
E1a oncogenes and plated them in clonogenic conditions.
Sox4lox/lox; AdCre MEFs showed a dramatically reduced number
of transformed foci compared with the Sox4+/+ controls, indica-
tive of reduced transformation abilities (Figure 6A). Given the
reduced cancer incidence in Sox4 hypomorphic mice (Figure 1I),
we wanted to study the impact of reduced Sox4 levels specif-
ically in skin carcinogenesis. For this purpose, we performed a
two-step, chemically induced carcinogenesis protocol. We
treated the mice with a single dose of 7,12-dimethylbenz[a]
anthracene (DMBA) and administered 12-O-tetradecanoylphor-
bol-13-acetate (TPA) twice weekly during 15 additional weeks in
order to promote expansion of cells bearing oncogenic muta-
tions induced by DMBA, most of which have been shown to
selectively cluster in the Ras pathway (Abel et al., 2009). We
monitored tumor burden once a week during a total of 35 weeks
after the first DMBA administration (Figure 6B). Interestingly, we
observed that the onset of tumors was delayed in Sox4cKO mice
(Figure 6C). Moreover, the average number of tumors per mouse
was notably reduced across the duration of experiment (Figures
6C and 6D). Of note, most of the papillomas that appeared in
Sox4cKO mice regressed upon TPA withdrawal, whereas up to
30% of the tumors that formed in Sox4WT became independent
of TPA administration and progressed (Figures 6C and 6E). In
addition, Sox4-depleted mice did not display any papilloma
larger than 6 mm after 30 weeks of treatment, in contrast to
more than 80% of Sox4WT mice (Figure 6E).ntiation Pathways during Plucking
ling, of Sox4WT and Sox4cKO mice during hair. Gene symbols are shown and
each gene.
GSEA in Sox4cKO versus Sox4WT mice after plucking.
gen or anagen in the absence of Sox4.
nonical Wnt/Ctnnb1 (Lien et al., 2014) (right) pathways, as inferred from GSEA.
en skin. Depicted is fold over Sox4WT for each gene.
). Student’s t test was used for comparison (*p < 0.05; **p < 0.01; ***p < 0.001).
e also Figure S5 and Tables S2–S5.
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Figure 6. Sox4 Is Required for Chemically
Induced Tumorigenesis
(A) Left: colony-forming assay using transformed
Sox4+/+ and Sox4lox/lox MEF transduced with
AdCre and Ras-IRES-E1A. Right: number of
transformed foci > 2 mm per mouse.
(B) Schematic representation of the TPA/DMBA
treatment. Red arrows, twice-weekly administra-
tion of TPA.
(C) Average number of tumors, stratified by size
(color coded) at the indicated weeks after TPA/
DMBA treatment in Sox4WT (left) and Sox4cKO
(right) mice. Red arrowhead, end of the TPA
treatment.
(D) Sox4WT (top) and Sox4cKO mice (bottom)
30 weeks after DMBA treatment.
(E) Average number of tumors (left, Student’s t test
compared with Sox4WT) and percentage of mice
bearing tumors > 6 mm (right, Fisher’s exact test
compared with Sox4WT).
(F) Schematic representation of the impact of Sox4
in cancer and aging. n, number of mice per ge-
notype; graphs are mean and SEM. Unless stated
otherwise, the statistics used were obtained by
Student’s t test.
See also Figure S6.We also studied carcinogenesis in Sox4cHET and Sox4 hypo-
morphic (Sox4lox/lox) mice. We observed a good correlation be-
tween Sox4 gene dosage and tumor burden, as assessed by
the total number of tumors and the percentage of mice bearing
big tumors (Figure 6E). The fact that Sox4cHET mice showed no
obvious global defects in weight, size, or lifespan, but displayed
a reduced number of tumors during TPA/DMBA owing to het-
erozygous deletion of Sox4 specifically in the skin, reinforces
the notion that Sox4 plays a role in chemically induced skin
carcinogenesis.
Resistance to TPA-Induced Proliferation Limits the Skin
Tumor Burden in the Absence of Sox4
We wanted to understand the mechanism by which Sox4 dele-
tion could contribute to preventing carcinogenesis. Given that
the papilloma burden in Sox4WT mice peaked between 12
and 15 weeks after TPA/DMBA administration (Figure 6C), we
decided to sacrifice a group of animals after 6 weeks of treat-
ment for a histological examination of skin prior to the onset of
tumors (Figures 6C and S6A). Interestingly, we found a strong
reduction in the percentage of proliferating cells, as assessed
by Ki67 staining, in the IFE of Sox4cKO mice, in agreement with496 Cell Reports 8, 487–500, July 24, 2014 ª2014 The Authorsa role for Sox4 in modulating the prolifer-
ative response under various stresses, as
previously shown for plucking and
wounding (Figures S6B and S6C).
Accordingly, these mice showed reduced
epidermal thickening and reduced HF
length, confirming that Sox4 is needed
for cell expansion upon mitogenic stimu-
lation (Figure S6C). We also studied the
levels and distribution of phosphorylatedHistone-3 (P-H3) by IHC in equivalent regions of benign lesions
fromSox4WT andSox4cKOmice, as determined from the distribu-
tion of the loricrin and CK6 markers. We observed a notable
reduction in the number of cells that were positive for P-H3. In
addition, themajority of theP-H3-positive cells inSox4cKOmouse
skin showed a dotted pattern, indicating G2 cell-cycle arrest
(Goto et al., 1999; Figure S6D). These findings are in line with
the defective activation and proliferation of HFSCs upon stimula-
tion we observed through both IHC and microarray profiling,
which included downregulation of many genes required for cell
division. These results suggest that the downregulation of cell-
cycle genes upon loss of Sox4may contribute to reduced tumor
formation associated with decreased Sox4 levels (Figure 6F).
DISCUSSION
Sox4 is a transcriptional activator that regulates the differenti-
ation and maturation of many cell types (Bhattaram et al.,
2010; Billiard et al., 2003; Lefebvre et al., 2007; Lioubinski
et al., 2003). In adults, Sox4 expression is restricted to the
proliferative female reproductive system, activated HFSCs
and HG cells, differentiating hematopoietic and lymphoid
compartments, and the CNS, suggesting that Sox4 is tightly
controlled (Greco et al., 2009; Hunt and Clarke, 1999; Kobielak
et al., 2007; Lien et al., 2014; Lowry et al., 2005; Vervoort et al.,
2013). Indeed, Sox4 is abnormally expressed in human cancer,
where it strongly correlates with poor prognosis and metas-
tasis (Vervoort et al., 2013).
Here, we sought to address the role of Sox4 in the adult organ-
ism. In particular, we generated hypomorphic Sox4 mice with
decreased Sox4 expression levels in the whole organism.
Reduced Sox4 levels in these mice are likely due to decreased
Sox4 mRNA stability associated with alteration of the 30 UTR
sequence of the Sox4 KI cassette (Amrani et al., 2004).
Decreased Sox4 levels in these mice lead to an earlier onset of
several age-related pathologies and reduced lifespan. We think
the decreased bone mineral density found in Sox4lox/lox (hypo-
morphic) mice is remarkable. Reduced Sox4 expression is asso-
ciated with postmenopausal bone frailty in humans (Duncan
et al., 2011; Jemtland et al., 2011). Moreover, Sox4+/ mice
show decreased osteogenesis and increased osteoporosis (Nis-
sen-Meyer et al., 2007), suggesting a role for Sox4 in regulating
bone homeostasis. Sox4lox/lox mice also show increased car-
diac malformations reminiscent of the developmental defects
that arise during late embryogenesis in Sox4/ embryos. The
absence of embryonic lethality in Sox4lox/lox mice suggests that
low Sox4 levels are sufficient to sustain full embryonic develop-
ment, but insufficient to ensure proper adult tissue homeostasis
(Schilham et al., 1996).
Interestingly,globaldownregulationofSox4mRNA inSox4lox/lox
mice also resulted in reduced cancer incidence, providing genetic
evidence for Sox4’s previously reported oncogenic activity
and overexpression in cancer (Penzo-Me´ndez, 2010; Vervoort
et al., 2013). To confirm that cancer resistance in Sox4lox/lox
mice was not a secondary effect of reduced lifespan, we gener-
ated mice conditionally deleted for Sox4 in the skin (Sox4cKO
mice). We confirmed that these mice are strongly resistant to
skin transformation in a two-step carcinogenesis protocol. The
reduced tumorigenesis in Sox4cKO, Sox4lox/lox, and Sox4cHET
mice and decreased Ras-induced foci in Sox4lox/lox AdCre MEFs
suggest that Sox4 is required for cellular transformation and
acts in a dose-dependent manner. This is likely to be mediated
by the resistance of Sox4 mice to respond to proliferation-
inducing agents, as shown by Ki67 and P-H3 staining in TPA-
treated skin, prior to the onset of tumorigenesis. Indeed, under
proliferative cues (such as with TPA treatment or hair plucking),
Sox4-deficientmiceshowedamuch reducedepidermal thickness
and HF length.
Sox4 is also relevant for normal HFSC activation. Upon pluck-
ing, the delayed HFSC activation in Sox4cKO mice resulted in a
significant delay in hair regeneration, as shown by assessment
of hair-coat regeneration dynamics, histology, and transcrip-
tional profiling. In agreement with this finding, a recent report
showing the contribution of mobilized Sox4-positive, activated
HFSC/HG and hair progeny to E6/E7 oncoprotein activity sug-
gested a link between HFSC activation and skin tumorigenesis
orchestrated through Sox4 expression (da Silva-Diz et al.,
2013). In line with this, a recent report showed that Sox2, another
member of the Sox superfamily, can also control skin tumorigen-
esis by modulating critical pathways related to tumor-initiatingcancer stem cells, thus connecting cancer with derailed stem-
ness. Interestingly, Sox2 seem to be induced in response to
TPA/DMBA and mutated Ras, in agreement with the behavior
of Sox4 in vitro and in vivo (Boumahdi et al., 2014). In support
of a connection between Sox2 and Sox4, it has been demon-
strated that autocrine TGF-b-mediated induction of Sox4 is crit-
ical for Sox2 upregulation to confer malignancy and stemness
features to glioma-initiating cells (Ikushima et al., 2009). Remark-
ably, we identified several gene sets that were specifically down-
regulated in Sox4-depleted skin during anagen, indicating an
important role for this protein during induction of the hair cycle.
Notably, some of these pathways are related to cell cycle and
DNA synthesis, which can account for an increased quiescence
of HFSCs depleted of Sox4 and thus reduced expansion of these
cell populations, in agreement with the observed longer telo-
meres in Sox4cKO mice HFSC compartments. In this regard, a
Wnt-dependent gene-expression signature that is activated
through Ctnnb1-mediated relief of Tcf3/4 repression during
hair plucking was elegantly elucidated in a recent study (Lien
et al., 2014). Interestingly, we detected a significant downregula-
tion of this Ctnnb1-sensitive signature in our microarray data in
Sox4cKO versus Sox4WT skin specifically during the hair-plucking
response. These results are indicative of an interplay between
the cues that govern hair regeneration with Sox4-mediated tran-
scription. Interestingly, when Sox4-depleted HFSCswere forced
to proliferate upon plucking, they displayed increased DNA
damage and reduced proliferation compared with their Sox4WT
littermates. This supports a role for Sox4 in HFSC activation
and points to a function for Sox4 in alleviating different types of
stress, as evidenced by increased gH2AX in cells depleted of
Sox4 under proliferative conditions, in agreement with previous
reports (Chetty et al., 2012). Finally, most of the DEGs in Sox4cKO
mice during plucking were linked to cancer, further supporting a
resistance to expansion and proliferation of epidermal keratino-
cytes during both physiological and pathological HFSC activa-
tion in the absence of Sox4 protein.
Overall, our results highlight the crucial roles that Sox4 has in
cancer and HFSC activation, and provide new avenues for eluci-
dating the roles of this transcription factor in vivo.
EXPERIMENTAL PROCEDURES
Mouse Experimentation
Mice were maintained at the Spanish National Cancer Research Center (CNIO)
under pathogen-free conditions, following the recommendations of the Feder-
ation of European Laboratory Animal Science Associations (FELASA).
Generation of the Sox4-IRES-GFP/Luciferase (Sox4KI) Mouse Model
Sox4KI mice were generated by genOway. All mice usedwere of amixed back-
ground (C57BL6/129Sv, 75%:25%).
Histopathology and IHC
Histology and IHC were performed as described previously (Martı´nez et al.,
2009) using the following antibodies and dilutions: mouse monoclonal
anti-GFP (Roche, 1:500), rabbit polyclonal anti-CK14 (Covance, 1:1,000),
rabbit polyclonal anti-CK10 (Covance, 1:300), rabbit polyclonal anti-Loricrin
(Covance, 1:500), rabbit polyclonal anti-p53 (CM5 Novocastra, 1:200), mouse
monoclonal anti-Ki67 (Master Diagnostica, 1:200), mouse monoclonal anti-
Histone 3 phospho-Ser10 (Millipore, 1:200), mouse monoclonal anti-Histone
2 phospho-Ser139 (gH2AX, Millipore, 1:100), mouse monoclonal anti-p63Cell Reports 8, 487–500, July 24, 2014 ª2014 The Authors 497
(Neo Markers, 1:100), and rat monoclonal anti-BrdU (Abcam, 1:50). Images
were captured in a bright-field microscope under 203 or 403 magnification
and quantified using ImageJ. At least 500–1,000 nuclei per skin region and
mouse were scored, and values were represented as the percentage of
positive nuclei per mouse.
Molecular Imaging
Lean mass, fat content, and bone mineral density were analyzed by DEXA
using a Lunar PIXImus Densitometer (GE Medical Systems) on mice anesthe-
tized with 2% isoflurane. The acquisition time was 5 min. Bone mineral den-
sity was calculated from a region of interest (ROI) including the whole left
femur.
Clonogenic Assays
Total keratinocytes from newborn or adult mice were isolated as described
previously (Jensen et al., 2010). Cells were resuspended in Cnt-02 medium
(CELLnTEC) and counted. Then 1 3 103 cells were seeded in triplicates onto
35 mm wells on top of MitomycinC-treated feeder layers in Cnt-02 medium
and cultured for 2 weeks. The cells were then fixed in 10% formaldehyde
(30 min at room temperature) and stained with Giemsa or rhodamine. Colonies
were counted and measured with ImageJ from scanned images. Each mouse
skin was plated in triplicate wells and averaged for individual mouse values,
and data were represented as the average per mouse.
Microarray-Based Transcriptional Profiling
Total RNA from resting or plucked skin was extracted with the QIAGEN
RNAlater and RNEasy Mini Kits. The RNA integrity number (RIN) was in
the range of 7–9.8 according to the Agilent 2100 Bioanalyzer. Total RNA
(100 ng) was labeled with the One-Color Microarray-Based Gene Expres-
sion Analysis (Low Input Quick Amp Labeling) kit (version 6.5; Agilent
Technologies) and purified with silica-based spin columns (BioRad). Hybrid-
ization and analysis were performed as described previously (Martı´nez et al.,
2013).
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